344
Participants
Start Date
July 31, 2005
Primary Completion Date
March 31, 2007
Study Completion Date
November 30, 2010
Cetuximab
"Cetuximab will always be administered first, followed by oxaliplatin at least 1 hour later. Following completion of the oxaliplatin infusion or simultaneously with oxaliplatin folinic acid (FA) will be administered (at a dose of 200 mg/m\^2, infused over 120 minutes, on day 1 and day 2, every two weeks) and then 5-Fluorouracil (5-FU) (as a bolus of 400 mg/m\^2/day intravenously (IV) over 2-4 minutes followed by 600 mg/m\^2/day infused over 22-hour, on day 1 and day 2, every two weeks).~Until progression or unacceptable toxicity develops"
Oxaliplatin
"Oxaliplatin will always be administered first or simultaneously with FA (at a dose of 200 mg/m\^2, infused over 120 minutes, on day 1 and day 2, every two weeks) and then 5-FU (as a bolus of 400 mg/m\^2/day IV over 2-4 minutes followed by 600 mg/m\^2/day infused over 22-hour, on day 1 and day 2, every two weeks).~Until progression or unacceptable toxicity develops"
Research Site, Graz
Research Site, Linz
Research Site, Salzburg
Research Site, Vienna
Research Site, Zams
Research Site, Antwerp
Research Site, Bonheiden
Research Site, Bruges
Research Site, Hasselt
Research Site, Leuven
Research Site, Roeselare
Research Site, Turnhout
Research Site, ZU Gent
Research Site, Besançon
Research Site, Clermond Ferrand
Research Site, Clichy
Research Site, Montpellier
Research Site, Paris
Research Site, Rouen
Research Site, Strasbourg
Research Site, Aschaffenburg
Research Site, Dresden
Research Site, Essen
Research Site, Hamburg
Research Site, Kiel
Research Site, Magdeburg
Research Site, Mannheim
Research Site, Nuremberg
Research Site, Tübingen
Research Site, Athens
Research Site, Loannina
Research Site, Thessaloniki
Research Site, Haifa
Research Site, Kfar Saba
Research Site, Petah Tikva
Research Site, Rehovot
Research Site, Tel Aviv
Research Site, Tel Litwinsky
Research Site, Brescia
Research Site, Milan
Research Site, Padua
Research Site, Pavia
Research Site, Rome
Research Site, Torino
Research Site, Bialystok
Research Site, Krakow
Research Site, Lublin
Research Site, Opole
Research Site, Poznan
Research Site, Szczecin
Research Site, Warsaw
Research Site, Lisbon
Research Site, Santa Maira Da Feira
Research Site, Alba Iulia
Research Site, Bucurest
Research Site, Onești
Research Site, Oradea
Research Site, Timișoara
Research Site, Kazan'
Research Site, Krasnodar
Research Site, Moscow
Research Site, Obninsk
Research Site, Saint Petersburg
Research Site, Samara
Research Site, Bilbao
Research Site, Burgos
Research Site, Girona
Research Site, Madrid
Research Site, Málaga
Research Site, Ourense
Research Site, Reus
Research Site, Valencia
Research Site, Dnipro
Research Site, Kharkiv
Research Site, Kiev
Research Site, Lviv
Research Site, Simferopol
Research Site, Vinnitsa
Merck KGaA, Darmstadt, Germany
INDUSTRY